Russian Heart Failure Journal 2005year Pharmaco-economic assessment of the therapy for heart failure with the β-blocker bisoprolol (international data and own experience)


To access this material please log in or register

Register Authorize
2005/

Pharmaco-economic assessment of the therapy for heart failure with the β-blocker bisoprolol (international data and own experience)

Belousov Yu.B.,Upnitsky  A.A., Erofeeva S.B.

Keywords:

DOI:

Expenses for management of patients with heart failure (HF) comprise about 1–2% of the health care budget. The major part of expenses is payments for inpatient care. Lecture considers the pharmaco-economic efficiency of bisoprolol in management of patients with chronic heart failure (CHF). Based on analysis of the large international studies CIBIS I and CIBIS II and own experience authors have shown that the use of bisoprolol not only provides a reduction of death rate in patients with CHF but also allows diminishment of expenses for their management in Russia.

To access this material please log in or register

Register Authorize
Ru En